ETC

Recommend
Index
  • Megarozet Tab.

    Megarozet Tab.

    Ingredient

    Ezetimibe/Rosuvastatin Calcium

    Content

    10/5mg, 10/10mg, 10/20mg

    Indication

    Treatment of primary hypercholesterolemia: As an adjunct to diet for the reduction of elevated total-C, LDL-C, apolipoprotein-B (apo-B), triglycerides, and non-high-density lipoprotein cholesterol (HDL-C), and to increase HDL-C in patients with primary (heterozygous familial and nonfamilial) hyperlipidemia or mixed hypercholesterolemia

  • Menactra®

    Menactra®

    Ingredient

    0.5-milliliter (mL) dose of MenQuadfi® to contain 10 µg each of meningococcal A, C, W, and Y polysaccharides conjugated to approximately 55 µg of tetanus toxoid protein carrier

    Content
    Indication

    r active immunization to prevent invasive meningococcal
    disease caused by Neisseria meningitidis serogroups A, C, Y and W-135. Menactra
    is approved for use in individuals 9 months through 55 years of age

  • Minjuvi™ Inj. 200mg

    Minjuvi™ Inj. 200mg

    Ingredient

    One vial of powder contains 200 mg of tafasitamab

    Content

    White to slightly yellowish lyophilised powder.

    Indication

    In combination with lenalidomide followed by MINJUVI monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) who are not eligible for autologous stem cell transplant (ASCT).

  • Munobal Tab.

    Munobal Tab.

    Ingredient

    Felodipine

    Content

    2.5mg, 5mg

    Indication

    Treatment of hypertension, stable angina pectoris.

TOP